Tissue Regenix Ltd:企業の製品パイプライン分析

◆英語タイトル:Tissue Regenix Ltd - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME125412PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥171,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥256,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tissue Regenix Ltd (Tissue Regenix), a subsidiary of Tissue Regenix Group PLC, is a medical technology company that offers replacement body parts from biological materials by using the dCELL technology platform. The company’s proprietary dCELL technology process is applied in markets such as vascular, biosurgery, cardiac and orthopaedics. Its products include human heart valve, tissue matrix, decellurised human dermis product, porcine meniscus, porcine tendon, donated human meniscus and donated human tendon. The company collaborates with universities and other institutions for its research activities. Tissue Regenix is headquartered in Leeds, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Tissue Regenix Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Tissue Regenix Ltd Company Overview
Tissue Regenix Ltd Company Snapshot
Tissue Regenix Ltd Pipeline Products and Ongoing Clinical Trials Overview
Tissue Regenix Ltd – Pipeline Analysis Overview
Tissue Regenix Ltd – Key Facts
Tissue Regenix Ltd – Major Products and Services
Tissue Regenix Ltd Pipeline Products by Development Stage
Tissue Regenix Ltd Ongoing Clinical Trials by Trial Status
Tissue Regenix Ltd Pipeline Products Overview
Cardiopure – Aortic Heart Valve
Cardiopure – Aortic Heart Valve Product Overview
Cardiopure – Pulmonary Heart Valve
Cardiopure – Pulmonary Heart Valve Product Overview
dCELL – Small Diameter Graft
dCELL – Small Diameter Graft Product Overview
dCELL Human Dermis – Plastic Surgery
dCELL Human Dermis – Plastic Surgery Product Overview
DermaPure – ACL Repair
DermaPure – ACL Repair Product Overview
Dermapure – Acute Wounds
Dermapure – Acute Wounds Product Overview
OrthoPure HM
OrthoPure HM Product Overview
Orthopure HT
Orthopure HT Product Overview
OrthoPure XM
OrthoPure XM Product Overview
OrthoPure XM Clinical Trial
Orthopure XT
Orthopure XT Product Overview
Orthopure XT Clinical Trial
Orthopure XT – LCL
Orthopure XT – LCL Product Overview
Orthopure XT – MCL
Orthopure XT – MCL Product Overview
Orthopure XT – MPFL
Orthopure XT – MPFL Product Overview
Orthopure XT – PCL
Orthopure XT – PCL Product Overview
Orthopure XT – PLC
Orthopure XT – PLC Product Overview
Tissue Regenix Ltd – Key Competitors
Tissue Regenix Ltd – Key Employees
Tissue Regenix Ltd – Locations And Subsidiaries
Head Office
Recent Developments
Tissue Regenix Ltd, Recent Developments
Oct 03, 2019: Tissue Regenix launches DermaPure product line extension specifically for surgical and trauma markets
Jun 04, 2019: Tissue Regenix Group: Annual results for the year ended 31 December 2018
Apr 04, 2019: Tissue Regenix Group: Expands US GPO coverage for DermaPure into 1,500 additional hospitals
Dec 17, 2018: Tissue Regenix’s decellularized human dermis product, DermaPure, demonstrated substantial clinical and cost benefits in case series presented at Cleveland Clinic accredited VEITH Symposium
Dec 05, 2018: Tissue Regenix Group: Interim management change
Nov 13, 2018: Tissue Regenix Group: Pan European distribution agreement with Arthrex
Sep 05, 2018: Tissue Regenix Group: Unaudited Interim Results for the six months ended 30 June 2018
Jul 04, 2018: Tissue Regenix Appoints Gareth Hywel Jones As Chief Financial Officer
May 02, 2018: TRX BioSurgery extends GPO agreement with Premier
Apr 24, 2018: Tissue Regenix announces successful completion of technical transfer for DermaPure manufacturing at CellRight Facility
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Tissue Regenix Ltd Pipeline Products and Ongoing Clinical Trials Overview
Tissue Regenix Ltd Pipeline Products by Equipment Type
Tissue Regenix Ltd Pipeline Products by Indication
Tissue Regenix Ltd Ongoing Clinical Trials by Trial Status
Tissue Regenix Ltd, Key Facts
Tissue Regenix Ltd, Major Products and Services
Tissue Regenix Ltd Number of Pipeline Products by Development Stage
Tissue Regenix Ltd Pipeline Products Summary by Development Stage
Tissue Regenix Ltd Ongoing Clinical Trials by Trial Status
Tissue Regenix Ltd Ongoing Clinical Trials Summary
Cardiopure - Aortic Heart Valve - Product Status
Cardiopure - Aortic Heart Valve - Product Description
Cardiopure - Pulmonary Heart Valve - Product Status
Cardiopure - Pulmonary Heart Valve - Product Description
dCELL - Small Diameter Graft - Product Status
dCELL - Small Diameter Graft - Product Description
dCELL Human Dermis - Plastic Surgery - Product Status
dCELL Human Dermis - Plastic Surgery - Product Description
DermaPure - ACL Repair - Product Status
DermaPure - ACL Repair - Product Description
Dermapure - Acute Wounds - Product Status
Dermapure - Acute Wounds - Product Description
OrthoPure HM - Product Status
OrthoPure HM - Product Description
Orthopure HT - Product Status
Orthopure HT - Product Description
OrthoPure XM - Product Status
OrthoPure XM - Product Description
OrthoPure XM - dCell Vascular Patch in Biological Repair for Damaged Menisci for CE Mark Submission
Orthopure XT - Product Status
Orthopure XT - Product Description
Orthopure XT - A Prospective, Non-comparative Clinical Investigation of a Novel Decellularised Porcine Xenograft (dCELL ACL Scaffold) for Reconstruction of the Anterior Cruciate Ligament
Orthopure XT - LCL - Product Status
Orthopure XT - LCL - Product Description
Orthopure XT - MCL - Product Status
Orthopure XT - MCL - Product Description
Orthopure XT - MPFL - Product Status
Orthopure XT - MPFL - Product Description
Orthopure XT - PCL - Product Status
Orthopure XT - PCL - Product Description
Orthopure XT - PLC - Product Status
Orthopure XT - PLC - Product Description
Tissue Regenix Ltd, Key Employees
Glossary

★海外企業調査レポート[Tissue Regenix Ltd:企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • WorleyParsons Ltd (WOR):企業の財務・戦略的SWOT分析
    WorleyParsons Ltd (WOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • TWi Pharmaceuticals Inc (4180):製薬・医療:M&Aディール及び事業提携情報
    Summary TWi Pharmaceuticals Inc (TWi), formerly Anchen Pharmaceuticals (Taiwan) Inc is a technology based pharmaceutical company that manufactures high barrier generics drugs. The company provides products such as donepezil hydrochloride tablets, hydroquinone cream, hydroquinone time release cream, …
  • PharmaLundensis AB:製薬・医療:M&Aディール及び事業提携情報
    Summary PharmaLundensis AB (PharmaLundensis) is a pharmaceutical company that develops drugs for lung diseases. The company develops drugs for chronic obstructive pulmonary disease (COPD), chronic bronchitis and influenza-induced lung failure. It also develops EcoFilter, a system that that eliminate …
  • Technogenetics srl:医療機器:M&Aディール及び事業提携情報
    Summary Technogenetics srl (Technogenetics), a subsidiary of Shanghai Kehua Bio-engineering Co Ltd, is an immunodiagnostics and molecular genetics company that offers reagents and instruments in the field of biotechnology and pharmacology. The company provides immunodiagnostics products in the areas …
  • International Seaways Inc (INSW):石油・ガス:M&Aディール及び事業提携情報
    Summary International Seaways Inc (INSW) owns and operates a fleet of oceangoing vessels involved in the transportation of crude oil and petroleum products. The company holds ownership in LNG (liquefied natural gas) carriers and FSO (floating storage and offloading) service vessels. It charters the …
  • Sandoz International GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Sandoz International GmbH (Sandoz), a subsidiary of Novartis AG develops, manufactures and commercializes generic pharmaceutical products. The company provides biosimilars, generic antibiotics, dermatology and transplantation medicines. Its biosimilars comprise Omnitrope, Binocrit and Zarzio …
  • 1-800-FLOWERS.COM, Inc. (FLWS):企業の財務・戦略的SWOT分析
    1-800-FLOWERS.COM, Inc. (FLWS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Development Center for Biotechnology-製薬・医療分野:企業M&A・提携分析
    Summary Development Center for Biotechnology (DCB) is a non-profit organization that provides support to biotechnology and pharmaceutical companies. The organization develops biotech industry through its cooperation and industrialization, key technologies, infrastructure building, research and devel …
  • EyePoint Pharmaceuticals Inc (PSDV):製薬・医療:M&Aディール及び事業提携情報
    Summary EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert and durasert, among others. Its durasert …
  • ReNeuron Group Plc (RENE):企業の財務・戦略的SWOT分析
    ReNeuron Group Plc (RENE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Cardif Lux Vie S.A.:企業の戦略・SWOT・財務情報
    Cardif Lux Vie S.A. - Strategy, SWOT and Corporate Finance Report Summary Cardif Lux Vie S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Arcontech Group PLC (ARC):企業の財務・戦略的SWOT分析
    Summary Arcontech Group PLC (Arcontech), formerly Knowledge Technology Solutions PLC, is a technology company that provides real-time market data management solutions. The company provides products and bespoke systems for collection, processing, distribution and presentation of financial markets dat …
  • Aiful Corp:企業の戦略・SWOT・財務分析
    Aiful Corp - Strategy, SWOT and Corporate Finance Report Summary Aiful Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • CME Group Inc.:戦略・SWOT・企業財務分析
    CME Group Inc. - Strategy, SWOT and Corporate Finance Report Summary CME Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Editas Medicine Inc (EDIT):製薬・医療:M&Aディール及び事業提携情報
    Summary Editas Medicine Inc (Editas Medicine) formerly Gengine Inc, is a discovery stage biotechnology company that develops genome level treatments for rare diseases. The company is developing a proprietary genome editing platform based on its in-licensed clustered regularly interspaced short palin …
  • Taiga Biotechnologies Inc-製薬・医療分野:企業M&A・提携分析
    Summary Taiga Biotechnologies Inc (Taiga Biotech) is a biopharmaceutical company that develops protein and cellular therapies. The company develops therapies for diseases including cancers and infectious diseases. Its pipeline products include programs such as stem cell therapy and target specific T …
  • Jyoti Structures Ltd (JYOTISTRUC)-エネルギー分野:企業M&A・提携分析
    Summary Jyoti Structures Ltd (JSL) is a turnkey engineering, procurement, and construction (EPC) services provider that designs, tests, manufactures, sources, constructs, and supplies transmission lines, substations, and microwave towers. It designs HVDC and river crossing transmission towers, subst …
  • Memorial Resource Development Corp-石油・ガス分野:企業M&A・提携分析
    Summary Memorial Resource Development Corp (Memorial Resource) is an independent natural gas and oil company. It focuses on the exploitation, development, and acquisition of natural gas, natural gas liquids (NGL) and oil properties, primarily in the Cotton Valley formation in North Louisiana. Its pr …
  • Qatar Fuel (WOQOD) (QFLS):企業の財務・戦略的SWOT分析
    Qatar Fuel (WOQOD) (QFLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Saint-Gobain Weber GmbH:企業の戦略・SWOT・財務情報
    Saint-Gobain Weber GmbH - Strategy, SWOT and Corporate Finance Report Summary Saint-Gobain Weber GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆